A detailed history of Xtx Topco LTD transactions in Merus N.V. stock. As of the latest transaction made, Xtx Topco LTD holds 9,066 shares of MRUS stock, worth $407,063. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,066
Previous 11,166 18.81%
Holding current value
$407,063
Previous $660,000 31.52%
% of portfolio
0.03%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$47.19 - $58.84 $99,099 - $123,564
-2,100 Reduced 18.81%
9,066 $452,000
Q2 2024

Aug 12, 2024

BUY
$39.81 - $60.2 $156,493 - $236,646
3,931 Added 54.33%
11,166 $660,000
Q1 2024

May 13, 2024

BUY
$28.03 - $51.82 $202,797 - $374,917
7,235 New
7,235 $325,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.06B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.